60
Participants
Start Date
April 18, 2017
Primary Completion Date
March 31, 2028
Study Completion Date
March 31, 2033
Daunorubicin
Given IV
Prednisolone
Given PO or IV
Vincristine
Given IV
Epirubicin
Given IV
E-coli L-asparaginase
Given IM or IV
6-Mercaptopurine
Given PO
Methotrexate
Given IV, PO or IT
Hydrocortisone
Given IT
Cytarabine
Given IV, IT or SC
Cyclophosphamide
Given IV
NOT_YET_RECRUITING
National Taiwan University Children's Hospital, Taipei
NOT_YET_RECRUITING
Chang Gung Memorial Hopsital, Linkou, Taoyuan District
RECRUITING
Mackay Memorial Hospital, Taipei
RECRUITING
Siriraj Hospital Mahidol University, Bangkok
NOT_YET_RECRUITING
Subang Jaya Medical Centre, Subang Jaya
NOT_YET_RECRUITING
University of Malaya Medical Centre, Kuala Lumpur
RECRUITING
National University Hospital, Singapore
RECRUITING
KK Women's and Children's Hospital, Singapore
RECRUITING
Prince of Wales Hospital, Shatin
RECRUITING
Kagoshima University Hospital, Kagoshima
National Hospital Organization Nagoya Medical Center
OTHER